Advanced understanding of cancer progression in circulating tumor cells using multiplexed imaging technology
Applied Spectral Imaging (Israel), MetaGene and QIMR Berghofer Medical Research Institute (Australia) have developed a multiplexed fluorescent imaging system to advance the understanding of disease progression in tissue, liquid biopsy and circulating tumor cells. The system offers a cost-effective, rapid, integrated solution for up to 24-plex* MIF analysis.
Original Research Article:
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch
Front. Immunol., 16 June 2020 | https://doi.org/10.3389/fimmu.2020.01228
*Dependent on Filter and Module selection.